Advanced Search:
Equity Index Forex Crypto Commodity

ETON - Eton Pharmaceuticals

$3.71  -0.04 (-1.07%)

Updated: 01:14 May 4, 2024 EST

Next Hour's AI Forecast

N/A

Avg. Accuracy (AI)

N/A

Next Session's AI Forecast

N/A

Avg. Accuracy (AI)

N/A

Next Week's AI Forecast

N/A

Trend's Accuracy (AI)

N/A

Eton Pharmaceuticals's Position Within the Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

ETON PHARMACEUTICALS - HISTORICAL DATA 6M

  • Last price

    $ 3.71

  • Daily change

    $ -0.04

  • Previous Close

    $ 3.75

  • Last Updated

    01:14 May 4, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-1.08 0.24 -0.34 -0.19 0.02

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.08 2.76 2.6 2.87 3.46

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
N/A 86.67% 94.2% 42.48%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
0 -100% 3.45 -1.43% 3.5 -14% 4.07

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
1.14 42.53 2 53.27

Eton Pharmaceuticals Technical Analysis News

Eton Pharmaceuticals

21925 West Field Parkway
Suite 235
Deer Park, IL 60010-7208
United States
847 787 7361
https://www.etonpharma.com

Description

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. It also develops ET-105, a lamotrigine for oral suspension; DS-300, a cysteine injection; DS-100, a dehydrated alcohol injection; ET-104, a zonisamide oral suspension; ET-101, a topiramate oral suspension; and ET-203, an ephedrine ready-to-use injection. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Corporate Governance

Eton Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

ETON PHARMACEUTICALS'S HOLDERS RANK

List of holders with stock participation in Eton Pharmaceuticals.

Holder Rank Holder Shares Date Reported % Out Value